Skip to Content
Contact Form Map & Directions Videos

Monthly Archives: May 2012

Pradaxa’s Life in the FDA Fast Lane — Profits Over Safety?

05/11/2012
Articles
BY

Pradaxa, an anti-coagulant drug marketed by Boehringer Ingelheim Pharmaceuticals, enjoyed an unusually smooth (and quick) ride towards FDA approval.  Rather than spending months pouring over clinical studies and safety data, FDA employees instead approved Pradaxa based primarily on a single study and did so in just six months.  Below are […]

Read More

DePuy ASR Hip Implant Case Update

05/11/2012
Defective Medical Devices
BY

So far this week, our firm has filed three new DePuy ASR hip implant cases in the MDL proceedings pending before Judge David A. Katz of the United States District Court in the Northern District of Ohio. These multi-district litigation proceedings related to DePuy’s recalled ASR hip implants are also […]

Read More

Tracking Drugs for Consumer Safety

05/3/2012
Articles
BY

The Institute of Medicine (IOM) is taking the U.S. Food and Drug Administration (FDA) to task. In a new report, the IOM says the FDA should conduct more regular reviews of drugs to better catch and track safety issues. In order to better inform patients and the doctors who treat […]

Read More

Lead Poisoning Threshold Lowered in Children

05/18/2012
Blog
BY

It has now been reported that for the first time in 20 years, U.S. health officials have lowered the threshold for lead poisoning in young children.  The new standard means hundreds and thousands of young children could be diagnosed with high levels of lead.  Too much lead is harmful to […]

Read More

Hear What Our Clients Have To Say

"Without question, a tier one law firm! I have been extremely pleased with the quality of service and their attention to detail. Everyone has been extraordinarily kind and professional. I highly recommend this fine organization!"
Posted By: Bud Wilder